Tudorza pressair approved for COPD

(HealthDay) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) in people 18 and older.

COPD, most often caused by smoking, encompasses chronic bronchitis and emphysema. Symptoms usually include , excessive phlegm and chest tightness, the FDA said in a news release.

The Tudorza Pressair inhaler, to be used twice daily, relaxes muscles around the lung's large airways, improving breathing. It is not meant to be used as a rescue inhaler during sudden asthma attacks, the agency said.

Common side effects observed during clinical testing included headache, nasal inflammation and cough.

The inhaler is distributed by St. Louis-based Forest Pharmaceuticals, a subsidiary of Forest Laboratories.

More information: Medline Plus has details about COPD.

add to favorites email to friend print save as pdf

Related Stories

Beta blockers may help COPD sufferers

May 12, 2011

(Medical Xpress) -- Beta blockers, the group of drugs commonly prescribed to patients with heart diseases, may also have considerable benefits for sufferers of diseases such as chronic bronchitis and emphysema, according ...

FDA phases out inhaler due to environmental impact

Sep 22, 2011

(AP) -- Asthma patients who rely on over-the-counter inhalers will need to switch to prescription-only alternatives as part of the federal government's latest attempt to protect the Earth's atmosphere.

Smokers' COPD risk is genetic

Mar 11, 2009

It's well known that puffing on cigarettes can eventually leave you out of puff. But why do a quarter of long-term smokers develop serious breathing problems, when others do not? New research published BioMed Central's open ...

New NIH data show gains in COPD awareness

Nov 09, 2010

The number of Americans who report being aware of chronic obstructive pulmonary disease, or COPD, increased by 4 percentage points between 2008 and 2010, but many people at risk are still unaware of the disease, according ...

Recommended for you

Meningococcal disease ID'd in men who have sex with men

6 hours ago

(HealthDay)—Following reports of invasive meningococcal disease (IMD) among men who have sex with men (MSM), the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has recommended that ...

Measles epidemic sweeps northern Syria

9 hours ago

An epidemic of measles is sweeping through parts of northern Syria, with at least 7,000 people affected because the ongoing civil war has disrupted vaccination programmes, Doctors Without Borders said on Tuesday.

Whooping cough has lifelong health impact, study finds

10 hours ago

People born during whooping cough outbreaks are more likely to die prematurely even if they survive into adulthood, research at Lund University in Sweden has found. Women had a 20% higher risk of an early death, and men a ...

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...